Charles River Laboratories Inte

Historical 13F Holders

Symbol
CRL
CUSIP
159864107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 159864107 since 12/18/2024, newest first.

Filer % of Class Filed
FMR LLC 13G/A Amendment 2
10.2% 9/8/2026
Event 8/31/2026
Invesco Ltd. 13G 6.2% 8/13/2026
Event 6/30/2026
FMR LLC 13G/A Amendment 1
8.8% 8/6/2026
Event 6/30/2026
Invesco Ltd. 13G/A Amendment 1 4.9% 5/6/2026
Event 3/31/2026
FMR LLC 13G
7.0% 5/6/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 7.4% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 14 0% 3/26/2026
Event 3/13/2026
Invesco Ltd. 13G 5.5% 2/12/2026
Event 12/31/2025
Wellington Management Group LLP 13G/A Amendment 3
3.6% 2/10/2026
Event 12/31/2025
Nomura Holdings Inc 13G/A Amendment 1 1.6% 11/14/2025
Event 9/30/2025
Wellington Management Group LLP 13G/A Amendment 2
6.5% 11/12/2025
Event 9/30/2025
Nomura Holdings Inc 13G 5.4% 8/14/2025
Event 6/30/2025
Wellington Management Group LLP 13G/A Amendment 1
8.4% 5/12/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 19 6.9% 4/17/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 47 370 k $109 M
2026 Q2 589 69.7 M $13.4 B
2026 Q1 582 57.7 M $9.95 B
2025 Q4 606 53.0 M $10.6 B
2025 Q3 582 50.8 M $7.97 B
2025 Q2 554 51.8 M $7.87 B
2025 Q1 589 53.4 M $8.04 B
2024 Q4 669 55.0 M $10.0 B
2024 Q3 660 52.8 M $10.4 B
2024 Q2 702 53.4 M $11.0 B
2024 Q1 712 53.6 M $14.5 B
2023 Q4 664 52.9 M $12.5 B
2023 Q3 659 52.0 M $10.2 B
2023 Q2 642 51.4 M $10.8 B
2023 Q1 657 51.7 M $10.4 B
2022 Q4 656 52.3 M $11.4 B
2022 Q3 615 50.5 M $9.95 B
2022 Q2 654 49.1 M $10.5 B
2022 Q1 676 47.6 M $13.5 B
2021 Q4 741 47.3 M $17.8 B
2021 Q3 706 47.0 M $19.4 B
2021 Q2 664 47.6 M $17.6 B
2021 Q1 585 47.2 M $13.7 B
2020 Q4 566 47.3 M $11.8 B
2020 Q3 517 46.9 M $10.6 B
2020 Q2 496 51.1 M $8.84 B
2020 Q1 435 46.9 M $6.07 B
2019 Q4 430 47.8 M $7.31 B
2019 Q3 415 47.3 M $6.27 B
2019 Q2 434 47.2 M $6.70 B
2019 Q1 437 46.8 M $6.79 B
2018 Q4 427 46.3 M $5.25 B
2018 Q3 386 47.6 M $6.40 B
2018 Q2 362 46.5 M $5.22 B
2018 Q1 345 47.2 M $5.03 B
2017 Q4 353 47.7 M $5.20 B
2017 Q3 344 45.9 M $4.96 B
2017 Q2 313 46.0 M $4.65 B
2017 Q1 312 47.4 M $4.26 B
2016 Q4 306 46.6 M $3.56 B
2016 Q3 289 46.2 M $3.85 B
2016 Q2 294 46.2 M $3.81 B
2016 Q1 269 47.0 M $3.57 B
2015 Q4 278 45.7 M $3.67 B
2015 Q3 265 46.1 M $2.93 B
2015 Q2 270 46.6 M $3.28 B
2015 Q1 263 46.8 M $3.71 B
2014 Q4 257 46.9 M $2.98 B
2014 Q3 263 46.9 M $2.80 B
2014 Q2 272 49.5 M $2.65 B
2014 Q1 271 48.1 M $2.90 B